Mizuho lowered the firm’s price target on Bill (BILL) to $53 from $70 and keeps a Neutral rating on the shares as part of a Q1 preview for the ...

Quantum computing sounded like science fiction just a few years ago—now it’s one of the hottest emerging industries on Wall Street. But while ...

President Donald Trump’s tariff playbook has emerged into one of the hottest global topics. Economies around the world are wondering how and if ...

Toyota (TM) just got a lifeline. Shares of the Japanese auto giant jumped 4.7% after U.S. President Donald Trump said he’s considering a pause ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on JNJ: Disclaimer & Disclosure Report an Issue Johnson & Johnson NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

China has ordered its airlines to halt further deliveries of Boeing (BA) jets as part of the tit-for-tat trade war that’s seen U.S. President ...

Canaccord raised the firm’s price target on Verve Therapeutics (VERV) to $39 from $32 and keeps a Buy rating on the shares. The firm said ...

Evercore ISI analyst Amit Daryanani lowered the firm’s price target on Arista Networks (ANET) to $100 from $130 and keeps an Outperform rating ...

Innovative Medicine: nipocalimab in gMG; RYBREVANT Sub-Q in NSCLC; TREMFYA Sub-Q in UC; TAR-200 NMIBC; icotrokinra in PsO and UC; RYBREVANT in ...

Wells Fargo downgraded Hexcel (HXL) to Equal Weight from Overweight with a price target of $55, down from $63.Stay Ahead of the Market: ...

Digital payments giant PayPal (PYPL) has joined hands with TerraPay, a global money transfer infrastructure provider, to allow instant ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $23.00.